Research progress of therapeutic vaccines for treating chronic hepatitis B
Hepatitis B virus (HBV) is a member of Hepadnavirus family, which leads to chronic infection in around 5% of patients with a high risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma. Despite the availability of prophylactic vaccines against hepatitis B for over 3 decades,...
Saved in:
Main Authors: | Jianqiang Li (Author), Mengru Bao (Author), Jun Ge (Author), Sulin Ren (Author), Tong Zhou (Author), Fengchun Qi (Author), Xiuying Pu (Author), Jia Dou (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiology and evolution of Norovirus in China
by: Na Wei, et al.
Published: (2021) -
A programme to treat chronic hepatitis B in Kiribati: progress and challenges
by: Alice U. Lee, et al.
Published: (2020) -
Hepatitis B Therapeutic Vaccine: A Patent Review
by: Shuaibu Abdullahi Hudu, et al.
Published: (2022) -
Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
by: Thomas F. Baumert
Published: (2019) -
Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas
by: Alba Maria Ropero Álvarez, et al.
Published: (2017)